Home›Companies›Biotech & Pharma›Aviv Pharma

Aviv Pharma Inc.

Develops and commercializes specialty and generic medicines for providers and patients.

No LinkedIn page we could confirm. Why?
Updated Nov 20, 2026·Latest SEC filing Dec 28, 2023·Suggest an edit

About Aviv Pharma

Aviv Pharma is a private company based in Reno, Nevada, incorporated in 2022 in Nevada. It has reported $2,252,517 raised in one offering on Form D since December 2023.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 15, 2023Dec 28, 2023$2,252,517of $4.0M target12$187KEquityRule 506(c)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Aviv Pharma's Form D filed Dec 28, 2023.

JG
Jeffrey Glazer
Executive officer and director
RR
RH
PE

Sources

  1. SECAviv Pharma Inc. filing history